ClinicalTrials.gov
ClinicalTrials.gov Menu

HuMax-CD20 in Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00093314
Recruitment Status : Withdrawn (Acquired asset)
First Posted : October 8, 2004
Last Update Posted : April 21, 2015
Sponsor:
Information provided by:
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : January 2007
  Actual Study Completion Date : January 2007
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):